Vera Therapeutics VERA
NASDAQ VERA
$30.42 -0.57 (-1.84%)
At close: Oct 2, 2026 · 4:00 PM EDT

Vera Therapeutics (VERA) Gains from Sales and Divestitures (2021)

Updated

Vera Therapeutics (VERA) posted Gains from Sales and Divestitures of $2.69 million for FY2021.

Analysis

Vera Therapeutics (VERA) Gains from Sales and Divestitures (2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Vera Therapeutics 2.19 Bn 2.19 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 2.69 Mn
API Access

Vera Therapeutics Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=VERA&period=max&api_key=YOUR_API_KEY